Medison Pharma announces public formulary listing of Qinlock (ripretinib) in Canadian provinces: Ontario and Quebec for advanced gastro-intestinal stromal tumour treatment

29 September 2023 - Medison Pharma is pleased to announce the public formulary listing of Qinlock in Canadian provinces: Ontario ...

Read more →

Pfizer and BioNTech receive Health Canada authorisation for XBB.1.5 adapted monovalent COVID-19 vaccine

28 September 2023 - The updated vaccine is expected to be available in Canada in the coming weeks. ...

Read more →

Ultragenyx launches Evkeeza (evinacumab for injection) in Canada for the treatment of homozygous familial hypercholesterolaemia

25 September 2023 - Evkeeza is a first in class medicine approved by Health Canada, the US FDA and European Commission ...

Read more →

argenx announces Vyvgart (efgartigimod alfa) authorised for sale by Health Canada for generalised myasthenia gravis

21 September 2023 - Approval based on the positive Phase 3 ADAPT trial (p<0.0001) showing 68% of Vyvgart treated patients were ...

Read more →

Health Canada authorises Moderna COVID-19 vaccine targeting the Omicron XBB.1.5 sub-variant

12 September 2023 - Health Canada has authorised the use of the Moderna Spikevax COVID-19 vaccine targeting the Omicron XBB.1.5 ...

Read more →

Health Canada accepts Valneva’s Chikungunya vaccine license application for review

29 August 2023 - Valneva today announced that Health Canada has completed screening validation of the Company’s regulatory application for ...

Read more →

Health Canada approves Alhemo (concizumab injection) for the treatment of patients living with haemophilia A with FVIII inhibitors

9 August 2023 - Health Canada has approved a new indication for Alhemo (concizumab injection) for the treatment of Canadian adolescent ...

Read more →

GSK's Arexvy, the first respiratory syncytial virus vaccine for older adults approved in Canada

4 August 2023 - Approval of Arexvy was based on a comprehensive Phase III clinical trial program that showed high vaccine ...

Read more →

Jazz Pharmaceuticals enters into letter of intent with the pan-Canadian Pharmaceutical Alliance for Rylaze, helping address the unmet need of acute lymphoblastic leukaemia and lymphoblastic lymphoma patients across Canada

2 August 2023 - Jazz Pharmaceuticals today announced that the Company has entered into a letter of intent with the pan-Canadian ...

Read more →

Health Canada authorises Tecvayli (teclistamab injection), a first in class bispecific antibody for the treatment of patients with relapsed or refractory multiple myeloma

2 August 2023 - Approval for Tecvayli, a subcutaneously administered therapy, is based on results from the Phase 1/2 MajesTEC-1 ...

Read more →

Mirum’s Livmarli now authorised in Canada for cholestatic pruritus in patients with Alagille syndrome

25 July 2023 - Approval supported by more than six years of Livmarli data demonstrating improvements in pruritus and serum bile ...

Read more →

Health Canada approves AbbVie's Rinvoq (upadacitinib) for the treatment of adults with moderately to severely active ulcerative colitis

25 July 2023 - Approval is based on results from three Phase 3 studies: two for induction and one for maintenance. ...

Read more →

Health Canada approves Trodelvy (sacituzumab govitecan) in pre-treated HR+/HER2- metastatic breast cancer

20 July 2023 - Trodelvy has now improved survival in both pre-treated HR+/HER2- metastatic breast cancer and in second-line metastatic ...

Read more →

Health Canada approves Lynparza in combination with abiraterone and prednisone or prednisolone for patients with BRCA mutated metastatic castration-resistant prostate cancer

13 July 2023 - Conditional approval based on data from Phase 3 PROpel trial. ...

Read more →

Lupin Announces Health Canada approval of tiotropium bromide inhalation powder for treatment of COPD

11 July 2023 - Lupin announced that on 26 May 2023, its Canada subsidiary, Lupin Pharma Canada received approval from ...

Read more →